Skip to main content

Table 1 Relationship between miR-361-5p expression and clinicopathologic features of BC patients (n = 60)

From: MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1

variable

Relative miR-361-5p expression

P-value

 

Low (n = 30)

High (n = 30)

 

Age

  

NS

 < 50

17

14

 

 > 50

13

16

 

Histological differentiation

  

NS

 Well

7

6

 

 Moderate

14

17

 

 Poor

9

7

 

ER status

  

NS

 Positive

16

17

 

 Negative

14

13

 

PR status

  

NS

 Positive

21

14

 

 Negative

9

16

 

Her-2 status

  

NS

 Positive

11

8

 

 Negative

19

22

 

Tumor size

  

P < 0.05

 < 2 cm

11

21

 

 2-5 cm

12

6

 

 > 5 cm

7

3

 

Lymph node metastasis

  

P < 0.01

 Yes

21

6

 

 No

9

24

 

Tumor stage

  

P < 0.05

 I

7

15

 

 II

12

11

 

 III

11

4

 

Molecular subtype

  

NS

 Luminal like

16

17

 

 HER-2 positive

10

7

 

 Triple negative

4

6

 
  1. Note: BC patients were divided into miR-361-5p High group and Low group according to the analysis of qRT-PCR detection. NS, not significant between different groups. Differences among variables were evaluated by χ2 or Fisher’s exact χ2 -test